NCT06084338 2025-12-31
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
VA Office of Research and Development
Phase 2 Recruiting
Clinical Trials
8 trialsNCT05011383 2025-07-09
VA-BAT
VA Office of Research and Development
Phase 2 Recruiting
NCT03339635 2024-07-30
Short-term Testosterone Replacement in Testicular Cancer Survivors
University Medical Center Groningen
Phase 2 Completed
NCT00587431 2023-11-07
Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT04424654 2022-08-03
PSMA-BAT
Hospital Sirio-Libanes
Phase 2 Completed
NCT01750398 2016-12-05
BAT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00853697 2015-10-30
Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00577980 2013-04-29
Testosterone in Castration-Resistant Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Withdrawn